NDC 0185-0724

Carisoprodol and Aspirin

Carisoprodol And Aspirin

Carisoprodol and Aspirin is a Oral Tablet in the Human Prescription Drug category. It is labeled and distributed by Eon Labs, Inc.. The primary component is Carisoprodol; Aspirin.

• Product ID: 0185-0724_926d8d39-3d4f-4f12-ba11-21c66ddd990e
• NDC: 0185-0724
• Product Type: Human Prescription Drug
• Proprietary Name: Carisoprodol and Aspirin
• Generic Name: Carisoprodol And Aspirin
• Dosage Form: Tablet
• Route of Administration: ORAL
• Marketing Start Date: 1996-04-25
• Marketing End Date: 2020-02-29
• Marketing Category: ANDA / ANDA
• Application Number: ANDA040116
• Labeler Name: Eon Labs, Inc.
• Substance Name: CARISOPRODOL; ASPIRIN
• Active Ingredient Strength: 200 mg/1; mg/1
• Pharm Classes: Centrally-mediated Muscle Relaxation [PE],Muscle Relaxant [EPC],Platelet Aggregation Inhibitor [EPC],Decreased Platelet Aggregation [PE],Cyclooxygenase Inhibitors [MoA],Decreased Prostaglandin Production [PE],Anti-Inflammatory Agents, Non-Steroidal [CS],Nonsteroidal Anti-inflammatory Drug [EPC]
• DEA Schedule: CIV
• NDC Exclude Flag: N

Packaging

NDC 0185-0724-01

100 TABLET in 1 BOTTLE (0185-0724-01)

• Marketing Start Date: 1996-04-25
• NDC Exclude Flag: N
• Sample Package?: N

NDC SPL Data Element Entries

NDC 0185-0724-05 [00185072405]

Carisoprodol and Aspirin TABLET

• Marketing Category: ANDA
• Application Number: ANDA040116
• Product Type: HUMAN PRESCRIPTION DRUG
• Billing Unit: EA
• Marketing Start Date: 1996-04-25
• Marketing End Date: 2018-04-30

NDC 0185-0724-10 [00185072410]

Carisoprodol and Aspirin TABLET

• Marketing Category: ANDA
• Application Number: ANDA040116
• Product Type: HUMAN PRESCRIPTION DRUG
• Marketing Start Date: 1996-04-25
• Marketing End Date: 1996-04-25

NDC 0185-0724-01 [00185072401]

Carisoprodol and Aspirin TABLET

• Marketing Category: ANDA
• Application Number: ANDA040116
• Product Type: HUMAN PRESCRIPTION DRUG
• Billing Unit: EA
• Marketing Start Date: 1996-04-25
• Marketing End Date: 2020-02-29

Drug Details

Active Ingredients

Ingredient	Strength
CARISOPRODOL	200 mg/1

OpenFDA Data

• SPL SET ID: 4d9f0f73-c6a5-405d-b0eb-fa14ab030682
• Manufacturer:
  • Eon Labs, Inc.
• UNII:
  • R16CO5Y76E
  • 21925K482H
• RxNorm Concept Unique ID - RxCUI:
  • 197447
• Pharm Class PE:
  • Decreased Prostaglandin Production [PE]
  • Decreased Platelet Aggregation [PE]
• PHarm Class EPC:
  • Nonsteroidal Anti-inflammatory Drug [EPC]
  • Platelet Aggregation Inhibitor [EPC]
• NUI Code:
  • N0000008832
  • N0000008836
  • N0000175721
  • N0000000160
  • N0000175578
  • N0000175722

Pharmacological Class

• Centrally-mediated Muscle Relaxation [PE]
• Muscle Relaxant [EPC]
• Cyclooxygenase Inhibitors [MoA]
• Decreased Prostaglandin Production [PE]
• Nonsteroidal Anti-inflammatory Compounds [Chemical/Ingredient]
• Nonsteroidal Anti-inflammatory Drug [EPC]
• Platelet Aggregation Inhibitor [EPC]
• Decreased Platelet Aggregation [PE]
• Anti-Inflammatory Agents
• Non-Steroidal [CS]

NDC Crossover Matching brand name "Carisoprodol and Aspirin" or generic name "Carisoprodol And Aspirin"

NDC	Brand Name	Generic Name
0185-0724	Carisoprodol and Aspirin	Carisoprodol and Aspirin
21695-570	Carisoprodol and Aspirin	Carisoprodol and Aspirin
23155-145	Carisoprodol and Aspirin	Carisoprodol and Aspirin
64980-175	CARISOPRODOL and ASPIRIN	CARISOPRODOL and ASPIRIN